Three leading UCT academics have published in The Lancet, one of the world leading medical journals, as part of a paper outlining the most recent advances in tuberculosis pathogenesis and management every 5 years.
An article co-authored by Prof Bob Millar, an IDM senior research fellow in the journal, Neuroendocrinology, reports on a novel effect of an antagonist of the brain hormone, on post-menopausal hot flushes which affect 60-80% of women.
A recent randomized controlled trial revealed that 53% more patients initiated therapy for tuberculosis (TB) after a new diagnostic tool (GeneXpert MTB/RIF) was used to screen for TB in more than 2 261 individuals in the community.
An international research team of University of Cape Town (UCT) and UK scientists has found clear evidence of a separate stage in tuberculosis (TB) infection where people have no symptoms but are more likely to go on and develop the full disease.
Access to essential CVD medicines is worryingly low globally and particularly in low- and middle-income countries (LMICs), where some of the barriers to CVD medicines access include poor access to health care facilities, lowavailability, poor quality of medication and unaffordability.
TB researchers suggest that urgent action, including rapid diagnosis, wider access to newer and repurposed drugs, and bolstering home-based care and building long term community stay facilities for patients are pivotal in addressing the rising transmission and infection rates of incurable TB.
The Dean of the Faculty of Health Sciences at the University of Cape Town, Professor Bongani Mayosi, has been elected to the US National Academy of Medicine (NAM). The NAM, formerly the Institute of Medicine, was established in 1970 under the charter of the National Academy of Sciences to advise on medical and health issues.